|
��չ����
|
|
| ������Ϣ | |
 |
Supporting info |
|
PDFȫ�� |
|
[HTMLȫ��] |
|
����� |
| �����뷴�� | |
|
�������ù����� |
|
���� |
|
Email Alert |
|
���·��� |
|
���������Ϣ |
| ���Ĺؼ���������� | |
|
��ŵ�ض� |
|
�ѷ� |
| ��������������� | |
|
������ |
|
�ｨ�� |
| PubMed | |
|
Article by |
|
Article by |
��ŵ�ض������ѷ���ҩ�����ٴ��о�
������, �ｨ��
�й�ҽѧ��ѧԺ���й�Э��ҽ�ƴ�ѧƤ�����о��� �Ͼ� 210042
��ŵ�ض�����ͨ������;���ٽ�ë������,������ŵ�ض�ϵͳ���ռ���.���г�ֵ��ٴ�����֤ʵ��ŵ�ض����ۼ������ѷ�����ͺ�нϺõ���Ч,���ģ���ٴ�������֤ʵ������ŵ�ض������ѷ��ǰ�ȫ��.������������ŵ�ض������ѷ��Ŀ��ܻ��ơ��ٴ��о��Ͳ�����Ӧ.
[2] Baker CA,Uno H,Johnson GA.Minoxidil sulfation in the hair follicle.Skin Pharmacol,1994,7:335-339.
[3] Meidan VM,Touitou E.Treatments for androgenetic alopecia and alopecia areata:current options and future prospects.Drugs,2001,61:53-69.
[4] Yano K,Brown LF,Detmar M.Control of hair growth and follicle size by VEGF-mediated angiogenesis.J Clin Invest,2001,107:409.
[5] KKhandpur S,Suman M,Reddy BS.Comparative efficacy of various treatment regimens for androgenetic alopecia in men.J Dermatol,2002,29:489-498.
[6] KFiedler-Weiss VC,West DP,Buys CM,et al.Topical minoxidil doseresponse effect in alopecia areata.Arch Dermatol,1986,122:180.
[7] Saraswat A,Kumar B.Minoxidil vs finasteride in the treatment of men with androgenet c alopecia.Arch De rmatol,2003,139:1219-1221.
[8] 0lsen EA,Dunlap EE,Funicella T,et al.A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men.J Am Acad Dermatol,2002,47:377-385.
[9] Price VH,Menefee E,Strauss PC.Changes in hair weight and hair count in men with androgenetic alopecia,after application of 5% and 2% topical minoxidil,placebo,or no treatment.J Am Acad Dermatol,1999,41:717-721.
[10] DeVillez RL,Jacobs JP,Szpunar CA,et al.Androgenetic alopecia in the female.Treatment with 2% topical minoxidil solution.Arch Dermatol,1994,130:303-307.
[11] Price VH,Menefee E.Quantitative estimation of hair growth.I.androgenetic alopecia in women:effect of minoxidil.J Invest Dermatol,1990,95:683-687.
[12] Fransway AF,Muller SA.3 percent topical minoxidil compared with placebo for the treatment of chronic severe alopecia areata.Cutis,1988,41:431-435.
[13] Duvic M,Lemak NA,Valero V,et al.A randomized trial of minoxidil in chemotherapy-induced alopecia.J Am Acad Dermatol,1996,35:74-78.
[14] Rodriguez R,Machiavelli M,Leone B,et al.Minoxidil(Mx) as a prophylaxis of doxorubicin-induced alopecia.Ann Oncol,1994,5:769-770.
[15] Shapiro J.Safety of topical minoxidil solution:a one-year,prospective,observational study.J Cutan Med Surg,2003,7:322-329.
[16] Dawber RP,Rundegren J.Hypertrichosis in females applying minoxidil topical solution and in normal controls.J Eur Acad Dermatol Venereol,2003,17:271-275.
[17] Peluso AM,Misciali C,Vincenzi C,et al.Diffuse hypertrichosis during treatment with 5% topical minoxidil.Br J Dermatol,1997,136:118-120.
[18] Friedman ES,Friedman PM,Cohen DE,et al.Allergic contact dermatitis to topical minoxidil solution:etiology and treatment.J Am Acad Dermatol,2002,46:309-312.
[19] Trattner A,David M.Pigmented contact dermatitis from topical minoxidil 5%.Contact Dermatitis,2002,46:246.